{"id":"https://openalex.org/W2062390260","doi":"https://doi.org/10.4088/jcp.v63n1011","title":"Olanzapine in Refractory Schizophrenia After Failure of Typical or Atypical Antipsychotic Treatment: An Open-Label Switch Study","display_name":"Olanzapine in Refractory Schizophrenia After Failure of Typical or Atypical Antipsychotic Treatment: An Open-Label Switch Study","alternate_titles":[],"publication_year":2002,"publication_date":"2002-10-15","ids":{"openalex":"https://openalex.org/W2062390260","doi":"https://doi.org/10.4088/jcp.v63n1011","mag":"2062390260","pmid":"https://pubmed.ncbi.nlm.nih.gov/12416603"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.v63n1011","doi":"https://doi.org/10.4088/jcp.v63n1011","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v63n1011","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2062390260"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088527002","display_name":"Jean\u2010Pierre Lindenmayer","orcid":"https://orcid.org/0000-0001-9358-8242","observed_orcids":["https://orcid.org/0000-0001-9358-8242"]},"institutions":[{"id":"https://openalex.org/I2799586594","display_name":"Manhattan Psychiatric Center","ror":"https://ror.org/05ykvn529","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799586594"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-Pierre Lindenmayer","raw_affiliation_strings":["Psychopharmacology Research Unit, Manhattan Psychiatric Center, Wards Island, NY 10035, USA. lindenmayer@nki.rfmh.org","Manhattan Psychiatric Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychopharmacology Research Unit, Manhattan Psychiatric Center, Wards Island, NY 10035, USA. lindenmayer@nki.rfmh.org","institution_ids":["https://openalex.org/I2799586594"]},{"raw_affiliation_string":"Manhattan Psychiatric Center","institution_ids":["https://openalex.org/I2799586594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062114165","display_name":"P\u00e1l Czobor","orcid":"https://orcid.org/0000-0002-6361-8006","observed_orcids":["https://orcid.org/0000-0002-6361-8006"]},"institutions":[{"id":"https://openalex.org/I2799586594","display_name":"Manhattan Psychiatric Center","ror":"https://ror.org/05ykvn529","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799586594"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pal Czobor","raw_affiliation_strings":["Manhattan Psychiatric Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Manhattan Psychiatric Center","institution_ids":["https://openalex.org/I2799586594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057648973","display_name":"Jan Volavka","orcid":"https://orcid.org/0000-0002-4178-8207","observed_orcids":["https://orcid.org/0000-0002-4178-8207"]},"institutions":[{"id":"https://openalex.org/I2799586594","display_name":"Manhattan Psychiatric Center","ror":"https://ror.org/05ykvn529","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799586594"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jan Volavka","raw_affiliation_strings":["Manhattan Psychiatric Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Manhattan Psychiatric Center","institution_ids":["https://openalex.org/I2799586594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075093461","display_name":"Jeffrey Alan Lieberman","orcid":"https://orcid.org/0000-0002-1899-1776","observed_orcids":["https://orcid.org/0000-0002-1899-1776"]},"institutions":[{"id":"https://openalex.org/I2799586594","display_name":"Manhattan Psychiatric Center","ror":"https://ror.org/05ykvn529","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799586594"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey A. Lieberman","raw_affiliation_strings":["Manhattan Psychiatric Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Manhattan Psychiatric Center","institution_ids":["https://openalex.org/I2799586594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013970045","display_name":"Leslie Citrome","orcid":"https://orcid.org/0000-0002-6098-9266","observed_orcids":["https://orcid.org/0000-0002-6098-9266"]},"institutions":[{"id":"https://openalex.org/I2799586594","display_name":"Manhattan Psychiatric Center","ror":"https://ror.org/05ykvn529","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799586594"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Leslie Citrome","raw_affiliation_strings":["Manhattan Psychiatric Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Manhattan Psychiatric Center","institution_ids":["https://openalex.org/I2799586594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015654560","display_name":"Brian Sheitman","orcid":"https://orcid.org/0000-0002-4924-5901","observed_orcids":["https://orcid.org/0000-0002-4924-5901"]},"institutions":[{"id":"https://openalex.org/I2799586594","display_name":"Manhattan Psychiatric Center","ror":"https://ror.org/05ykvn529","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799586594"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Brian Sheitman","raw_affiliation_strings":["Manhattan Psychiatric Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Manhattan Psychiatric Center","institution_ids":["https://openalex.org/I2799586594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110053360","display_name":"Miranda Chakos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799586594","display_name":"Manhattan Psychiatric Center","ror":"https://ror.org/05ykvn529","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799586594"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Miranda Chakos","raw_affiliation_strings":["Manhattan Psychiatric Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Manhattan Psychiatric Center","institution_ids":["https://openalex.org/I2799586594"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109121499","display_name":"Joseph P. McEvoy","orcid":"https://orcid.org/0000-0002-0047-5124","observed_orcids":["https://orcid.org/0000-0002-0047-5124"]},"institutions":[{"id":"https://openalex.org/I2799586594","display_name":"Manhattan Psychiatric Center","ror":"https://ror.org/05ykvn529","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799586594"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joseph P. McEvoy","raw_affiliation_strings":["Manhattan Psychiatric Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Manhattan Psychiatric Center","institution_ids":["https://openalex.org/I2799586594"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2799586594"],"apc_list":null,"apc_paid":null,"fwci":2.5533,"has_fulltext":false,"cited_by_count":69,"citation_normalized_percentile":{"value":0.88657788,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"63","issue":"10","first_page":"931","last_page":"935"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9900000095367432},{"id":"https://openalex.org/keywords/refractory-schizophrenia","display_name":"refractory schizophrenia","score":0.8410000205039978},{"id":"https://openalex.org/keywords/treatment-resistant-schizophrenia","display_name":"treatment-resistant schizophrenia","score":0.8360000252723694},{"id":"https://openalex.org/keywords/schizoaffective-disorder","display_name":"schizoaffective disorder","score":0.9459999799728394},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8130000233650208},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.8650000095367432},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9929999709129333},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antipsychotic-switching","display_name":"antipsychotic switching","score":0.7559999823570251},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.41100001335144043},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.8529999852180481},{"id":"https://openalex.org/keywords/positive-and-negative-syndrome-scale","display_name":"PANSS","score":0.4129999876022339},{"id":"https://openalex.org/keywords/length-of-illness","display_name":"length of illness","score":0.7459999918937683},{"id":"https://openalex.org/keywords/antipsychotic-treatment-response","display_name":"antipsychotic treatment response","score":0.46399998664855957},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.4390000104904175}],"concepts":[{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.9237374663352966},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.7210278511047363},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.658401608467102},{"id":"https://openalex.org/C2780325297","wikidata":"https://www.wikidata.org/wiki/Q834047","display_name":"Schizoaffective disorder","level":3,"score":0.6403119564056396},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.6339800357818604},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.6210510730743408},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6114449501037598},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.5517133474349976},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5377312898635864},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.48115432262420654},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4781644940376282},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.451264888048172},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.44490131735801697},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.430146187543869},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.35210540890693665},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30128213763237},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001480","descriptor_name":"Basal Ganglia Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.v63n1011","doi":"https://doi.org/10.4088/jcp.v63n1011","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v63n1011","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:12416603","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12416603","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G386912294","display_name":null,"funder_award_id":"MH 33127","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G482795097","display_name":"RISPERIDONE AND CLOZAPINE IN CHRONIC SCHIZOPHRENIA","funder_award_id":"R10MH053550","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2039163742","https://openalex.org/W2067892283","https://openalex.org/W2158832244","https://openalex.org/W1984513132","https://openalex.org/W2094817135","https://openalex.org/W2085295082","https://openalex.org/W2517335359","https://openalex.org/W2016431358","https://openalex.org/W1967034969","https://openalex.org/W2016849258"],"abstract_inverted_index":{"BACKGROUND:":[0],"When":[1],"patients":[2,42,91,280,358],"with":[3,39,43,67,193,304,359,369],"schizophrenia":[4,44,69],"fail":[5],"to":[6,8,16,51,75,77,110,135,172,176,364,386],"respond":[7,76],"an":[9,34,370],"atypical":[10,18,371],"antipsychotic,":[11],"they":[12],"are":[13],"sometimes":[14],"switched":[15],"another":[17],"compound.":[19],"However,":[20],"the":[21,98,102,116,128,138,168,194,233,259,289,297,305],"benefits":[22],"of":[23,104,107,122,127,137,151,279,307],"such":[24],"a":[25,80,105,145,229,254,320,328,362],"switch":[26,363],"have":[27],"not":[28,376],"been":[29,58,93],"adequately":[30],"studied.":[31],"We":[32],"present":[33,117],"open-label":[35,173],"prospective":[36],"14-week":[37,81,129],"trial":[38,83,100],"olanzapine":[40,212,365],"in":[41,97,147,218,296,323,331,357,379],"and":[45,55,88,155,179,196,205,253,327],"schizoaffective":[46,71],"disorder":[47,72],"whose":[48],"treatment":[49,78,133,171,213,367],"resistance":[50,134],"clozapine,":[52,85],"olanzapine,":[53,86,174],"risperidone,":[54,87],"haloperidol":[56,374],"had":[57,92],"determined":[59],"prospectively.":[60],"METHOD:":[61],"The":[62,90,294],"subjects":[63],"were":[64,119,165,180,190,284],"45":[65],"inpatients":[66],"DSM-IV":[68],"or":[70,161,223,373],"who":[73],"failed":[74],"during":[79],"double-blind":[82,99,130,170],"comparing":[84],"haloperidol.":[89],"selected":[94],"for":[95,115,182,232,258],"participation":[96],"on":[101],"basis":[103],"history":[106],"suboptimal":[108],"response":[109],"previous":[111,169],"treatment.":[112],"Inclusion":[113],"criteria":[114],"study":[118],"(1)":[120],"completion":[121],"at":[123],"least":[124],"8":[125],"weeks":[126,184],"trial,":[131],"(2)":[132],"1":[136],"4":[139],"compounds":[140],"tested":[141],"as":[142,286],"evidenced":[143],"by":[144],"decrease":[146,322],"total":[148,157],"PANSS":[149,158,219,234,298],"score":[150,159],"less":[152],"than":[153],"20%,":[154],"(3)":[156],">":[160],"=":[162,241,246,249,264,269,272,282,310,313,335,345,348],"60.":[163],"Subjects":[164],"cross-titrated":[166],"from":[167],"10":[175],"40":[177],"mg/day,":[178],"treated":[181],"14":[183],"without":[185],"concomitant":[186],"psychotropic":[187],"medication.":[188],"Patients":[189],"evaluated":[191],"weekly":[192],"Positive":[195],"Negative":[197],"Syndrome":[198],"Scale":[199],"(PANSS),":[200],"Clinical":[201],"Global":[202],"Impressions":[203],"scale,":[204],"Extrapyramidal":[206],"Symptom":[207],"Rating":[208],"Scale.":[209],"RESULTS:":[210],"Open-label":[211],"yielded":[214],"no":[215],"significant":[216,230,256,329],"change":[217,240,263],"total,":[220],"positive":[221],"subscale,":[222],"negative":[224],"subscale":[225],"scores.":[226],"There":[227,318],"was":[228,301,319],"improvement":[231],"cognitive":[235,387],"factor":[236,261,300],"(mean":[237,262,333],"+/-":[238,243,266,337,341],"SD":[239],"0.92":[242],"2.27;":[244],"F":[245,268,344],"7.5,":[247],"df":[248,271,312,347],"1,44;":[250,273],"p":[251,274,315,350],"<.009)":[252],"marginally":[255],"worsening":[257,295],"excitement":[260,299],"-1.36":[265],"4.64;":[267],"4.0,":[270],"<":[275,316],".053).":[276],"Nine":[277],"percent":[278],"(N":[281],"4)":[283],"classified":[285],"responders":[287],"using":[288],"Kane":[290],"et":[291],"al.":[292],"criteria.":[293],"significantly":[302],"associated":[303],"length":[306],"illness":[308],"(t":[309],"-2.10,":[311],"44,":[314],".04).":[317],"nonsignificant":[321],"extrapyramidal":[324],"side":[325],"effects":[326],"increase":[330,334],"weight":[332],"3.5":[336],"6.2":[338],"kg":[339],"[7.8":[340],"13.8":[342],"lb];":[343],"5.29,":[346],"1,42;":[349],"<.0005).":[351],"CONCLUSION:":[352],"Our":[353],"results":[354],"indicate":[355],"that":[356],"treatment-resistant":[360],"schizophrenia,":[361],"after":[366],"failure":[368],"agent":[372],"may":[375,382],"reduce":[377],"psychopathology":[378],"general,":[380],"but":[381],"improve":[383],"symptoms":[384],"related":[385],"function.":[388]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2062390260","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
